| Followers | 785 |
| Posts | 128093 |
| Boards Moderated | 9 |
| Alias Born | 09/26/2011 |
Friday, February 27, 2015 12:09:55 PM
$BICX - BioCorRx Inc. ~ The Start Fresh Program ® (SFP) consists of two components:
1.) BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opiates for as long as a year in some patients, depending on individual metabolism rates and other factors. Furthermore, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings for alcohol continue to remain greatly reduced or even eliminated.
2.) BioCorRx also owns a life-coaching program that is tailored specifically to substance abuse addicts. Once a patient has received the implant, they are encouraged to enter the life-coaching program to maximize results.
BioCorRx’s revolutionary Start Fresh Program ® has an unprecedented success rate as reported by the independently owned and operated clinics using the SFP. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life-coaching program without co-workers or family members knowing, unless they so choose.
Naltrexone blocks the parts of the brain that “feel pleasure” when patients use alcohol or opioids. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol or drugs and even if a substance is used, the effects of it can be extremely limited – making sobriety the best option. Once medical intervention has reduced the physical need for alcohol or opioids, the program goes on to address the patient’s psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.
1.) BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opiates for as long as a year in some patients, depending on individual metabolism rates and other factors. Furthermore, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings for alcohol continue to remain greatly reduced or even eliminated.
2.) BioCorRx also owns a life-coaching program that is tailored specifically to substance abuse addicts. Once a patient has received the implant, they are encouraged to enter the life-coaching program to maximize results.
BioCorRx’s revolutionary Start Fresh Program ® has an unprecedented success rate as reported by the independently owned and operated clinics using the SFP. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life-coaching program without co-workers or family members knowing, unless they so choose.
Naltrexone blocks the parts of the brain that “feel pleasure” when patients use alcohol or opioids. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol or drugs and even if a substance is used, the effects of it can be extremely limited – making sobriety the best option. Once medical intervention has reduced the physical need for alcohol or opioids, the program goes on to address the patient’s psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
